International (United States origin)

INS Infusion Therapy Standards of Practice, 9th Edition (2024)

1001 controls. 0 other frameworks in our corpus share controls with it. Here is all of it, and how much of it you are already doing.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

1001 controls 0 frameworks share controls with it International (United States origin) verified against its source document

Every control below is one this framework asks for. The right hand column counts how many other frameworks in our corpus carry the same control, which is the difference between doing this work once and doing it again for the next standard.

There is no implementation kit for this framework yet. The control list and the overlap above are free and complete.

What you already have

Frameworks whose controls overlap this one, most first. If you run any of them, the count is roughly what you have already evidenced.

No measured overlap with another framework in the corpus.

Every control

Showing 400 of 1001. The kit carries all of them.

CodeControlAlso in
1.1Applicability across populations and settings0
1.2Compliance with jurisdictional law0
1.3Written policies and standard protocols0
1.4Care that is safe, high quality and tailored to the patient0
1.5Ethical basis and advocacy for the patient0
1.6Evidence over commercial influence0
10.1Record every part of the infusion care episode0
10.2Accurate dated and attributed entries0
10.3Legible timely and retrievable records0
10.4Records show continuity quality and safety0
10.5Documentation confidentiality and privacy policy0
10.ARecord consent and how the patient responded0
10.BStandardised electronic record elements0
10.CInsertion details recorded at the time0
10.DOngoing site and securement review0
10.EComplications recorded with a standard tool0
10.FDocument how therapy was given0
10.GEquipment and maintenance responsibility recorded0
10.HOngoing need for the device reviewed0
10.IRemoval documented in full0
10.JStandard templates without limiting detail0
10.KUse electronic records and standard terms0
10.LRoutine documentation audits0
10.MCapture post treatment patient reported symptoms0
11.1Record and report adverse events0
11.2Safety science defined in policy0
11.AUse standard tools to track adverse events0
11.BTeach patients to spot complications0
11.CReport to the right recipients in time0
11.DInvestigate serious events and act0
11.E.1Build a safety and reliability culture0
11.E.2Fix systems rather than blame people0
11.E.3Examine at risk behaviour and coach0
11.E.4Support teamwork and changes to how work is done0
11.E.5Simplify and standardise reporting0
11.E.6Use a systematic safety method0
11.E.7Monitor investigation recommendations0
11.E.8Patient safety raised on rounds0
11.FA culture of openness and reporting0
11.GShare learning and change practice0
11.HResponsible disclosure of errors0
11.IInclude the patient in event review0
11.JMatch skills and staffing to reduce harm0
11.KSupport second victims of events0
12.1End users help judge products0
12.2End users keep product knowledge current0
12.3Check products before, during and after use0
12.4Remove and report expired or defective stock0
12.5Experts guide product substitution0
12.AJudge products against set criteria0
12.BReport product problems and monitor alerts0
13.1Controlled substance policies across medication pathway0
13.2Nonpunitive culture for diversion reporting0
13.3Competency for staff with substance access0
13.4Valid order for every controlled substance dose0
13.ARun a diversion prevention programme0
13.B.1Opioid stewardship programme0
13.B.10Handle waste of unused controlled substances0
13.B.2Background checks before employment0
13.B.3Careful review of controlled substance orders0
13.B.4Electronic prescribing of controlled substances0
13.B.5Limit who can reach controlled substance storage0
13.B.6Chain of custody for controlled substances0
13.B.7Diversion education at orientation and after0
13.B.8Diversion content in health care curricula0
13.B.9Approved administration steps for controlled substances0
13.C.1Duty to report suspected diversion0
13.C.2Drug testing where the law permits0
13.C.3Resolving controlled substance discrepancies0
13.C.4Routine audits of the medication pathway0
13.C.5Removing an impaired worker from care0
13.C.6Reporting confirmed diversion externally0
13.C.7Managing outbreaks linked to diversion0
13.D.1Confidentiality and recovery support0
13.D.2Addiction treated as chronic illness0
13.D.3Watch practice after a worker returns from recovery0
14.1Reducing latex presence in the environment0
14.2Latex free protective equipment and supplies0
14.AIdentifying clinicians with latex allergy0
14.BIdentifying patients at risk of latex allergy0
14.CRecord and share a positive latex screen0
14.DTell latex sensitivity apart from true allergy0
14.ERecognising latex exposure routes0
14.FUse nonpowdered gloves without latex0
14.GMinimising latex exposure for at risk people0
14.HAllergist input to procurement decisions0
14.ITeach patients and clinicians about anaphylaxis0
15.1Hazardous drug handling compliance0
15.2Safe handling across drug lifecycle0
15.3Hazardous waste container disposal0
15.AHazardous drug exposure protection0
15.BHazardous drug list upkeep0
15.CHazardous drug labeling0
15.DExposure risk points and controls0
15.EHierarchy of exposure controls0
15.FPPE use and competency0
15.GReproductive and breastfeeding precautions0
15.HSurface wipe sampling0
15.IMedical surveillance program0
15.JHazardous drug training and competency0
15.K.1Closed-system transfer in compounding0
15.L.1Protective devices for administration0
15.L.2Aseptic preparation inside containment0
15.L.3Disposal of container with set0
15.L.4Back-priming outside containment0
15.L.5Pre-infusion connection inspection0
15.MSpill preparedness and response0
15.NImmediate exposure response0
15.OHazardous waste segregation0
15.PBody fluid precautions after dose0
15.Q.1Home spill kit and cleaning0
15.Q.2Home laundry decontamination0
15.Q.3Home diaper and glove disposal0
16.1Regulated medical waste compliance0
16.2Needlestick risk in quality program0
16.3Sharps container requirements0
16.4Safety-engineered device availability0
16.ANeedlestick prevention during procedures0
16.BSharps and waste education0
16.CExposure reporting and follow-up0
16.DMedical waste checklist0
16.EEnvironmental impact of waste0
16.FPackaging and ANTT choice0
16.GHome infusion waste instruction0
16.HMedical waste sorting0
17.1Routine hand hygiene0
17.AHand hygiene moments0
17.BAlcohol-based hand rub use0
17.CSoap and water indications0
17.DCaution with chlorhexidine hand hygiene0
17.EHand hygiene supply access0
17.FFingernail care rules0
17.GJewelry removal for procedures0
17.HPatient hand hygiene education0
17.IMultimodal compliance strategy0
17.JHand hygiene monitoring and feedback0
17.KClinician product evaluation0
18.1Standard precautions for all patient care0
18.2PPE selection by exposure risk0
18.3Frequent cleaning of nearby surfaces0
18.4Prompt blood and body fluid spill cleanup0
18.5DME cleaning after every use0
18.AHand hygiene during standard precautions0
18.BPPE access and timely removal0
18.CGlove use and change rules0
18.DSingle-use gown or apron use0
18.EEye and face splash protection0
18.FUniversal PPE during high transmission0
18.GRespiratory hygiene and cough etiquette0
18.HDME disinfection with approved products0
18.IHome care bag and equipment hygiene0
18.JMultimodal standard precautions training0
19.1ANTT for all infusion procedures0
19.2ANTT education for clinicians and caregivers0
19.AStandardize aseptic technique with ANTT0
19.BANTT as a core clinical competency0
19.CKey-Part and Key-Site protection0
19.D.1Choosing ANTT approach through procedure risk assessment0
19.D.2Standard-ANTT for short, simple procedures0
19.D.3Surgical-ANTT for procedures that are complex0
19.EAseptic device disinfection and skin prep0
19.FSterile dressing and securement with ANTT0
19.GCare setting decontamination before procedures0
19.HAuditing and maintaining ANTT competency0
2.1What special patient populations need0
2.A.1Therapy considerations for neonatal and paediatric patients0
2.A.2Preterm infant skin and antiseptics0
2.A.3Child anatomy and access that is difficult0
2.A.4Psychosocial and cultural planning0
2.A.5Involving family and caregivers0
2.A.6Assent from school-aged and adolescent patients0
2.B.1Pregnancy physiology and dosing0
2.B.2Teaching about medication risk in pregnancy0
2.B.3Indication-only peripheral access in labour0
2.B.4PICC risk and hyperemesis nutrition0
2.C.1Ageing physiology and access that is harder0
2.C.2Assessing cognition, dexterity and social factors0
2.C.3Safe self-management at home0
2.C.4Involving family and surrogates0
2.C.5Polypharmacy and interaction risk0
2.C.6Dialysis access in elderly patients0
20.1Transmission-Based Precautions triggers0
20.2Contact Precautions for contact spread0
20.3Droplet Precautions for respiratory droplets0
20.4Airborne Precautions for airborne pathogens0
20.5Precautions in nonacute care settings0
20.6Precautions during crises of infectious disease0
20.APPE for transmission-based precautions0
20.BHand hygiene around PPE use0
20.CDuration of Transmission-Based Precautions0
20.DContact Precautions with gown and gloves0
20.EDroplet Precautions with mask and eye cover0
20.FAirborne Precautions and the respirator program0
20.GEnhanced barrier precautions in nursing homes0
20.HTelling others about suspected infection on transfer0
20.IEquipment that is dedicated and cleaned0
20.JCrisis strategies for care in a pandemic0
21.1Vascular visualization to improve insertion success0
21.AHistory review to judge insertion difficulty0
21.BUltrasound vessel assessment before cannulation0
21.C.1Visible light devices for superficial veins0
21.C.2Cold light only in visualization devices0
21.D.1Near infrared light for access that is difficult in children0
21.D.2Near infrared guidance in adult patients0
21.ECatheter to vessel ratio below 45 percent0
21.F.1Ultrasound guidance for peripheral catheters in adults0
21.F.2Ultrasound guidance for peripheral catheters in children0
21.GReal time ultrasound guidance for central device insertion0
21.HUltrasound guidance when puncturing arteries and placing catheters0
21.IProbe cover and disinfection between uses0
21.JUltrasound training from novice to expert0
21.KAssess and record visualization competence0
22.1Confirm tip position before infusion therapy0
22.2Record the original tip position and share it0
22.3Safest tip position at the cavoatrial junction0
22.AEstimate catheter length before insertion0
22.BTip target by insertion route0
22.CAvoid suboptimal tip positions0
22.DNo intracardiac tip in infants under one year0
22.EReal time tip location during insertion0
22.FReassess tip position on suspicion of malposition0
22.GVerify tip before starting infusion0
22.HAccepting external catheters after transfer0
22.IDocument insertion time and tip location0
23.1Basis for choosing flow control devices0
23.2Anti free flow sets with electronic pumps0
23.AMatching flow control to patient and therapy0
23.BMonitor flow control devices during infusion0
23.CStandardize pump types across the organization0
23.DReduce alarm and alert fatigue0
23.EFlow control devices during care transitions0
23.FTeach home users about flow control devices0
24.1Dedicated blood and fluid warming devices0
24.2Warming technique that limits hemolysis0
24.ACompetency for warming device operators0
24.BClinical indications for warming blood and fluids0
24.CApproved warming equipment and safeguards0
24.DTemperature limits and patient monitoring0
24.EWarming contrast media safely0
25.1Collaborative infusion and access decisions0
25.2Device selection based on prescribed therapy0
25.3Least invasive device with fewest lumens0
25.4Site selection based on vessel health0
25.I.AAssess infusate suitability for peripheral veins0
25.I.BDiscuss preferred peripheral site with patient0
25.I.CVisualisation for midline vein selection0
25.I.DAvoid peripheral sites at nerve risk0
25.I.EAvoid compromised peripheral insertion areas0
25.I.FDo not use trunk or breast veins0
25.I.GRestrict lower extremity vein use0
25.I.HPeripheral device not an infection prevention substitute0
25.I.IPrefer existing port over new device0
25.II.AShort peripheral site choice and removal0
25.II.BVisualisation for difficult intravenous access0
25.II.CNo continuous irritant or vesicant via short catheter0
25.II.DRestricted concentrations for peripheral nutrition0
25.II.EAvoid deep and subcutaneous veins0
25.II.FSmallest gauge catheter and monitoring0
25.III.ALong peripheral catheter when vessel is unseen0
25.III.BLong peripheral catheter vein and tip position0
25.IV.AAssess infusates before midline use0
25.IV.BMidline tip position distal to axillary fold0
25.IV.CConsider anti biofilm midline catheter0
25.IV.DMidline exclusions for vesicants and nutrition0
25.IV.EIncrease surveillance during irritant infusions0
25.IV.FAvoid midline in thrombosis and renal risk0
25.V.APaediatric peripheral catheter criteria and sites0
25.VI.AAvoid venipuncture with lymphedema risk0
25.VI.BVein preservation with renal dysfunction0
25.VI.CAvoid paralysed or hemiparetic limb0
25.VII.A.1Direct route versus skin tunnel0
25.VII.A.2Evidence based central access indications0
25.VII.A.3Central access after failed peripheral attempts0
25.VII.A.4Know the pressure limits for power injection0
25.VII.A.5Team choice of central device type0
25.VII.B.1PICC vein selection and catheter-to-vessel ratio0
25.VII.B.2Avoid tender, wounded, or damaged veins0
25.VII.C.1Ultrasound for non tunnelled central insertion0
25.VII.C.2Risk-based site selection for central catheters0
25.VII.D.1Atypical tunnelled noncuffed central catheter0
25.VII.D.2Tunnelled femoral PICC to the middle of the thigh0
25.VII.E.1Collaborative site selection for tunnelled devices0
25.VII.E.2Prefer internal jugular over other sites0
25.VII.E.3Ultrasound assessment of chest veins0
25.VII.E.4Tunnelled device for long term continuous therapy0
25.VII.E.5Port for intermittent access needs0
25.VII.E.6Nonconventional access for exhausted veins0
25.VIII.AArterial catheter indications0
25.VIII.BSmallest gauge for radial arterial access0
25.VIII.CUltrasound for arterial catheter placement0
25.VIII.DChecking hand circulation before radial puncture0
25.VIII.ERadial artery as first choice in adults0
25.VIII.FSites for arterial access in children0
26.1Skin antisepsis before each port access0
26.2Noncoring needle use for port access0
26.3Sterile dressing over an accessed port0
26.APain preferences during port access0
26.BUse the existing port before new access0
26.CAseptic technique for port access0
26.DSmallest noncoring needle for the therapy0
26.EPort flushing and locking to keep it patent0
26.FDressing and securement of the accessed port needle0
26.GChecking a port for power injection0
26.HAnnual imaging check of port position0
26.IEducation for patients and caregivers with ports0
27.1Choosing a dialysis access device jointly0
27.2Protect the fistula or graft arm0
27.3Restricted access to dialysis catheter lumens0
27.AProtecting vessels in people on dialysis0
27.BAseptic care of dialysis access sites0
27.CHub care and catheter lumen disinfection0
27.DLocking solutions for hemodialysis catheters0
27.ESurveillance of dialysis adverse events0
27.FPatient engagement and dialysis education0
28.1Daily review of umbilical catheter need0
28.AOrganisational guidance on umbilical catheters0
28.BSkin antisepsis for umbilical catheter insertion0
28.C.1Tip placement for umbilical arterial catheters0
28.C.2Tip placement for umbilical venous catheters0
28.DEstimating and confirming catheter length0
28.EImaging confirmation of umbilical catheter tip0
28.FSecurement of umbilical catheters0
28.GNo antibiotic ointment on umbilical sites0
28.HWatching for umbilical catheter complications0
28.ICare bundle for umbilical catheter infection0
28.JPrompt removal of umbilical catheters0
29.1Vascular access choice for therapeutic apheresis0
29.ACriteria for selecting an apheresis access device0
29.BPeripheral or central access for apheresis0
29.CDialysis-capable catheters for apheresis0
29.DLong-term apheresis ports0
29.EAvoid fistulas and grafts for long-term apheresis0
3.1Qualified and competent clinicians0
3.2Defined roles and accountability0
3.3Team collaboration for safe therapy0
3.4Rules for delegating infusion and access work0
3.ALicensure and defined scope0
3.BHow scope of practice is defined0
3.CUsing a scope-of-practice decision framework0
3.DTeam roles and shared scope boundaries0
3.EThe five rights of delegation0
3.FNursing roles in infusion therapy0
3.GUnlicensed assistive personnel limits0
3.HOther disciplines and jurisdictional variation0
30.1Right to pain management0
30.2Strategies to reduce needle-related pain0
30.ARealistic pain expectations and shared decisions0
30.BFirst-attempt success as pain reduction0
30.CBarriers to using pain relief strategies0
30.D.1Pain assessment in infants0
30.D.2Pain assessment in toddlers0
30.D.3Pain assessment in preschool and school-age children0
30.D.4Pain assessment in children with intellectual disability0
30.D.5Pain assessment in adults0
30.E.1Parent involvement in neonatal pain management0
30.E.2Nonpharmacologic relief for neonatal pain0
30.E.3Avoid anesthetic cream in neonates0
30.E.4Culturally based comfort strategies for infants0
30.E.5Massage therapy for neonatal procedural pain0
30.F.1Parents managing a child's procedural pain0
30.F.2Distraction techniques for children0
30.GIce before venipuncture in children0
30.H.1Topical anesthetics compared for children0
30.H.2Topical versus needleless lidocaine for child insertions0
30.H.3Vapocoolant spray for children0
30.I.1Needle phobia in adult patients0
30.I.2Nonpharmacologic pain relief for adults0
30.I.3Pharmacologic pain relief for adults0
31.1Skin antisepsis before device insertion0
31.2Clean site before antiseptic application0
31.AHair removal at the insertion site0
31.BAntiseptic allergy history check0
31.CChoice of skin antiseptic solution0
31.DSingle-use applicator and full drying0
32.1Single sterile device per attempt0
32.2Device used within manufacturer instructions0
32.3CVAD tip position verified before use0
32.4Patient education before device insertion0
32.I.ALocal PIVC insertion bundle0
32.I.BEarly referral for difficult access0
32.I.CPain relief for insertion0
32.I.DVisualisation for vein assessment0
32.I.E.1Ultrasound guidance for long PIVC0
32.I.E.2Vessel depth for long PIVC0
32.I.E.3Long PIVC in monitored settings0
32.I.FAids to distend peripheral veins0
32.I.GAseptic technique for PIVC insertion0
32.I.HLimit PIVC attempts per clinician0
32.I.IMidline catheter length and tip0
32.I.JImmediate PIVC removal triggers0
32.II.ACentral line bundle at CVAD insertion0
32.II.BUltrasound guidance when inserting a CVAD0
32.II.CRight-sided PICC and vein ratio0
32.II.DManage CVAD insertion complications0
32.II.ECVAD tip at cavoatrial junction0
32.II.FComplex CVAD insertion with cardiac devices0
32.III.AUltrasound for arterial access0
32.III.BDynamic needle tip positioning for arteries0
32.III.CAttire and drape for arterial catheter0
32.III.DSurgical ANTT for central arterial access0

Tell me when INS Infusion Therapy Standards of Practice, 9th Edition (2024) files something new

One email when a public company newly discloses something this framework governs, naming the company and what our corpus says it puts in scope. Nothing else, and one click to stop.

What this page is

A control-level reference for INS Infusion Therapy Standards of Practice, 9th Edition (2024), drawn from our framework corpus. Control codes and titles are references to the standard, not reproductions of it. The overlap counts and the auditor artefacts are our own work and are the part you will not find elsewhere.

Measure this against what you already run · All frameworks · Today's edition